Rolitetracycline
![]() | |
![]() | |
Clinical data | |
---|---|
ATC code | J01AA09 (WHO) |
Identifiers | |
| |
Synonyms | (2Z,4S,4aS,5aS,6S,12aS)-4-dimethylamino-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione |
CAS Number |
751-97-3 ![]() |
PubChem (CID) | 5282179 |
DrugBank |
DB01301 ![]() |
ChemSpider |
10469507 ![]() |
UNII |
GH9IW85221 ![]() |
KEGG |
D02282 ![]() |
ChEMBL |
CHEMBL1214184 ![]() |
ECHA InfoCard | 100.010.938 |
Chemical and physical data | |
Formula | C27H33N3O8 |
Molar mass | 527.566 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Rolitetracycline is a tetracycline antibiotic. Tetracycline is N-Mannich base prodrug that is prepared from tetracycline by condensation with pyrrolidine and formaldehyde to produce rolitetracycline.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.